(Q47586016)

English

Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients

scientific article published on 24 May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/21605893

Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/21605893

0 references

metastatic breast cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Andreas Schneeweiss

8

object named as

Andreas Schneeweiss

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

1

object named as

Bahriye Aktas

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/21605893

author name string

Volkmar Müller

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/21605893

Mitra Tewes

3

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/21605893

Julia Zeitz

4

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/21605893

Sabine Kasimir-Bauer

5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/21605893

Christian R Loehberg

6

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/21605893

Brigitte Rack

7

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/21605893

Tanja Fehm

9

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/21605893

language of work or name

0 references

publication date

24 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/21605893

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/21605893

122

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/21605893

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/21605893

356-360

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/21605893

Endocrine therapy for advanced breast cancer: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Concordance and discordance of estrogen and progesterone receptor content in sequential biopsies of patients with advanced breast cancer: relation to survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Impact of metastatic estrogen receptor and progesterone receptor status on survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Circulating tumor cells as markers for cancer risk assessment and treatment monitoring

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Quantitative real-time RT-PCR of disseminated tumor cells in combination with immunomagnetic cell enrichment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic inefficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Role of estrogens and their receptors in adhesion and invasiveness of breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Change of HER-2/neu status in a subset of distant metastases from breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Estrogen receptor expression profile of disseminated epithelial tumor cells in bone marrow of breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.039

7 January 2021

Identifiers

10.1016/J.YGYNO.2011.04.039

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/21605893

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/21605893

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47586016&oldid=2160797826"